Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus
- PMID: 20472147
- DOI: 10.1016/S0083-6729(10)82018-7
Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus
Abstract
The neuropeptides corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) are crucially involved in the pathogenesis of depression. The close correlation between the etiology of depression and dysregulation of the stress responses is based upon a hyperactivity of the hypothalamo-pituitary-adrenal (HPA) axis. CRH neurons in the paraventricular nucleus are the motor of the HPA-axis. Centrally released CRH, AVP, and increased levels of cortisol all contribute to the signs and symptoms of depression. Single-nucleotide polymorphisms in the CRH and AVP receptor genes are associated with the risk for depression. Activation of the HPA-axis is generally regarded to be the final common pathway of the pathogenesis of depression. Sex hormones are crucially involved in the regulation of CRH gene expression. The decreased activity of the biological clock, the suprachiasmatic nucleus, as indicated by its lower AVP expression, is the basis for the disturbed rhythms in depression. Both similarities and differences are found in the activity changes in the CRH and AVP systems in depressive disorders and depression in Alzheimer's disease.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
A comparison of two repeated restraint stress paradigms on hypothalamic-pituitary-adrenal axis habituation, gonadal status and central neuropeptide expression in adult male rats.J Neuroendocrinol. 2010 Feb;22(2):92-101. doi: 10.1111/j.1365-2826.2009.01941.x. Epub 2009 Dec 4. J Neuroendocrinol. 2010. PMID: 20002965
-
The stress system in depression and neurodegeneration: focus on the human hypothalamus.Brain Res Rev. 2008 Mar;57(2):531-53. doi: 10.1016/j.brainresrev.2007.04.005. Epub 2007 Apr 27. Brain Res Rev. 2008. PMID: 17524488 Review.
-
An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.J Psychiatr Res. 2007 Jan-Feb;41(1-2):131-43. doi: 10.1016/j.jpsychires.2005.12.005. Epub 2006 Feb 7. J Psychiatr Res. 2007. PMID: 16455105
-
The stress system in the human brain in depression and neurodegeneration.Ageing Res Rev. 2005 May;4(2):141-94. doi: 10.1016/j.arr.2005.03.003. Ageing Res Rev. 2005. PMID: 15996533 Review.
-
Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.Exp Neurol. 2000 Dec;166(2):376-84. doi: 10.1006/exnr.2000.7502. Exp Neurol. 2000. PMID: 11085902
Cited by
-
LD block disorder-specific pleiotropic roles of novel CRHR1 in type 2 diabetes and depression disorder comorbidity.Eur Arch Psychiatry Clin Neurosci. 2023 Dec 14. doi: 10.1007/s00406-023-01710-x. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 38092990
-
Methyleugenol Has an Antidepressant Effect in a Neuroendocrine Model: In Silico and In Vivo Evidence.Pharmaceuticals (Basel). 2023 Oct 4;16(10):1408. doi: 10.3390/ph16101408. Pharmaceuticals (Basel). 2023. PMID: 37895879 Free PMC article.
-
Vasopressin as Possible Treatment Option in Autism Spectrum Disorder.Biomedicines. 2023 Sep 22;11(10):2603. doi: 10.3390/biomedicines11102603. Biomedicines. 2023. PMID: 37892977 Free PMC article. Review.
-
Vasopressin as a Possible Link between Sleep-Disturbances and Memory Problems.Int J Mol Sci. 2022 Dec 7;23(24):15467. doi: 10.3390/ijms232415467. Int J Mol Sci. 2022. PMID: 36555107 Free PMC article. Review.
-
Potential of Heterogeneous Compounds as Antidepressants: A Narrative Review.Int J Mol Sci. 2022 Nov 9;23(22):13776. doi: 10.3390/ijms232213776. Int J Mol Sci. 2022. PMID: 36430254 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
